Bio-Trials to Complement Existing Quintiles Latin American Organization
RESEARCH TRIANGLE PARK, N.C., Oct. 30 /CNW/ -- Quintiles Transnational
Corp. today announced that its Latin American subsidiary has purchased
Bio-Trials, a leading Central American Clinical Research Organization (CRO)
with headquarters in Panama and offices in Costa Rica, Guatemala, Ecuador and
Bio-Trials provides clinical monitoring, clinical site coordination,
regulatory support, study management and supply distribution services. It has
conducted about 30 clinical trials in 10 Central and South American countries,
and its customers have included a number of major pharmaceutical companies and
"The acquisition of Bio-Trials gives Quintiles an experienced, well-
established team as well as access to an experienced network of independent
investigators in the increasingly important Central American region," said
Jeff Thomis, President of Global Clinical Development Services for Quintiles.
"Our customers are increasingly including Central America as part of their
global drug development program. The Bio-Trials team will be a welcome
addition to our Latin America group."
In addition to its offices, Bio-Trials has supply distribution points in
Panama, Costa Rica, Guatemala and Peru.
About Quintiles Latin America
Quintiles Latin America was founded in 1995 and now has nearly 600
employees in six countries, with headquarters in Argentina, providing project
management, clinical trial monitoring, regulatory, drug safety, site
management, quality assurance, central laboratory and clinical trial supplies
services. Quintiles Latin America has conducted more than 300 studies
involving more than 30,000 patients.
About Quintiles Transnational
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With more than 19,000
employees and offices in more than 50 countries, it is focused on providing
customer-centric solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at www.qtrn.com.
For further information:
For further information: Dick Jones, Media Relations, +1-919-998-2091,
firstname.lastname@example.org, or Greg Connors, Investor Relations,
+1-919-998-2000, email@example.com Web Site: http://www.qtrn.com